EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transarterial interventional therapy for bladder cancer: a narrative review

Yue Zhao, Wenzhe Fan, Xinlin Zheng, Nianjin Xu, Bowen Zhu, Weihong Zhang, Ge Zhang, Dequan Yang, Yiyang Tang, Jiaping Li

Holistic Integrative Oncology · 10.11.2026 · 5 (1)

DOI: 10.1007/s44178-026-00301-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Holistic Integrative Oncology, online erschienen am 10.11.2026. Verfasst von Yue Zhao und 9 weiteren Autor:innen. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Scientific and Technological Project of Guangdong Province, Clinical characteristic technology projects in Guangzhou City, The National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder cancer remains clinically challenging due to high recurrence rates, risk of progression, and the morbidity of current standard treatments. Transarterial interventional therapies — including intra-arterial chemotherapy (IAC), balloon-occluded arterial infusion (BOAI), transcatheter arterial chemoembolization (TACE), and transcatheter arterial embolization (TAE) — have been increasingly investigated as locoregional approaches in bladder cancer management. IAC shows encouraging outcomes across adjuvant, neoadjuvant, and bladder-preservation settings; BOAI has been associated with favorable outcomes in bladder-preservation protocols for organ-confined muscle-invasive disease; and TAE has been used as a palliative strategy for refractory malignant hematuria, with emerging application as a preoperative adjunct. Evidence for TACE remains preliminary. Given the distinct therapeutic goals of these approaches, reported outcomes should be interpreted according to the specific clinical setting. Across all techniques, available data derive predominantly from retrospective single-center studies with heterogeneous protocols, limiting generalizability. Accordingly, these approaches may currently be viewed as complementary or investigational options in selected patients, while their role relative to established standards of care requires further evaluation. This review summarizes the technical principles, clinical applications, current evidence, and future directions of transarterial interventional therapy for bladder cancer.

Förderung

  • Major Scientific and Technological Project of Guangdong Province
  • Clinical characteristic technology projects in Guangzhou City
  • The National Natural Science Foundation of China

Zitieren

APA

Zhao, Y., Fan, W., Zheng, X., Xu, N., Zhu, B., Zhang, W., Zhang, G., Yang, D., Tang, Y., & Li, J. (2026). Transarterial interventional therapy for bladder cancer: a narrative review. Holistic Integrative Oncology, 5(1). https://doi.org/10.1007/s44178-026-00301-9

Vancouver

Zhao Y, Fan W, Zheng X, Xu N, Zhu B, Zhang W, et al. Transarterial interventional therapy for bladder cancer: a narrative review. Holistic Integrative Oncology. 2026;5(1). doi:10.1007/s44178-026-00301-9

BibTeX
@article{Zhao2026,
  author = {Zhao, Yue and Fan, Wenzhe and Zheng, Xinlin and Xu, Nianjin and Zhu, Bowen and Zhang, Weihong and Zhang, Ge and Yang, Dequan and Tang, Yiyang and Li, Jiaping},
  title = {Transarterial interventional therapy for bladder cancer: a narrative review},
  journal = {Holistic Integrative Oncology},
  year = {2026},
  volume = {5},
  number = {1},
  doi = {10.1007/s44178-026-00301-9}
}
Kostenlos starten →